½ÃÀ庸°í¼­
»óǰÄÚµå
1598797

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå : ·¹ÀÌÀú À¯Çüº°, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Urology Medical Lasers Market by Laser Type (Diode Laser System, Holmium Laser System, Thulium Laser System), Application (Benign Prostatic Hyperplasia, Non-Muscle-Invasive Bladder Cancer, Urolithiasis) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀåÀº 2023³â 12¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 13¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 9.65% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 23¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀåÀÇ ¹üÀ§¿¡´Â Àü¸³¼± ºñ´ëÁõ, ¿ä·Î °á¼®, Á¾¾ç, ÇùÂø µî ´Ù¾çÇÑ ºñ´¢±â°ú ÁúȯÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ·¹ÀÌÀúÀÇ Çʿ伺Àº ÁÖ·Î Á¤¹Ð¼º, ÃÖ¼Ò ÃâÇ÷·®, ±âÁ¸ ¼ö¼ú ¹æ¹ý¿¡ ºñÇØ ªÀº ȸº¹ ½Ã°£À¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. º´¿ø, ºñ´¢±â°ú Ŭ¸®´Ð ¹× ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿¡ Àû¿ëµÇ¾î ȯÀÚÀÇ Ä¡·á ¿É¼ÇÀ» °­È­Çϰí ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÇÕÇÕ´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ »ç¿ë ºÎ¹®¿¡´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¹× ºñ´¢±â°ú °Ç°­ °ü¸®¿¡ ÁßÁ¡À» µÐ ½Ã¼³ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ºñ´¢±â°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, ·¹ÀÌÀú ±â¼úÀÇ ¹ßÀü, °í·ÉÈ­, Àü ¼¼°è ÀÇ·á Á¢±Ù¼º È®´ë µîÀÌ ÀÖ½À´Ï´Ù. ÆÄÀ̹ö ·¹ÀÌÀú ±â¼ú°ú °°Àº ±â¼ú Çõ½Å°ú Á¦Ç° °³¹ßÀ» À§ÇÑ ÆÄÆ®³Ê½ÊÀº »õ·Î¿î ¼ºÀåÀÇ ±æÀ» ¾à¼ÓÇÕ´Ï´Ù. ½ÃÀåÀº ½ÅÈï±¹¿¡¼­ÀÇ ºü¸¥ äÅðú Á¦Á¶¾÷ü¿Í ÀÇ·á±â°üÀÇ Àü·«Àû Çù·ÂÀ¸·Î ÀÎÇØ »ó½Â¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¹Ý¸é, ³ôÀº Àåºñ ºñ¿ë, ¼÷·ÃµÈ ¿î¿µÀÚÀÇ Çʿ伺, ±ÔÁ¦ Àå¾Ö¹°, »óȯ ¹®Á¦ µîÀÌ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. °æÀï ȯ°æÀº ·¹ÀÌÀú¿Í Á¶Á÷ÀÇ »óÈ£ ÀÛ¿ë¿¡ ´ëÇÑ ¿¬±¸ÀÇ ¹ßÀüÀ¸·Î Á¤ÀÚ À̵¿¼º °³¼± ¹× Á¶Á÷ ÀýÁ¦¼ú °­È­¿Í °°Àº »õ·Î¿î ÀÀ¿ë °¡´É¼ºÀÌ µå·¯³ª¸é¼­ ¹Ì°³Ã´ ºÐ¾ß¿¡ Å« ±âȸ°¡ ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. Çõ½ÅÀº ¼ÒÇü ÈÞ´ë¿ë ·¹ÀÌÀú ÀåÄ¡¿Í Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á ÃÖÀûÈ­¸¦ À§ÇØ AI¸¦ ÅëÇÕÇÑ ·¹ÀÌÀú ÀåÄ¡ÀÇ ¹ßÀüÀ¸·Î ÃËÁøµÉ ¼ö ÀÖ½À´Ï´Ù. ·¹ÀÌÀú ¼³°èÀÇ Áö¼Ó°¡´É¼º°ú ºñ¿ë È¿À²¼ºÀº °æÀï ¿ìÀ§¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. À¯¸ÁÇÑ Àü¸Á¿¡µµ ºÒ±¸Çϰí, ´ëü Ä¡·á ¹× ¼ö¼úÀû ´ë¾È°úÀÇ °æÀïÀ¸·Î ÀÎÇÑ ÇѰ谡 ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. Àü·«Àû Á¦¾ÈÀ¸·Î´Â ÀÇ·áÁø ±³À° ¹× ÈÆ·Ã¿¡ ÁýÁßÇϰí, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¸¶ÄÉÆÃ¿¡ ÅõÀÚÇϸç, Á¦Ç° µµ´Þ ¹üÀ§¿Í ¼ö¿ë¼ºÀ» Çâ»ó½Ã۱â À§ÇØ Á¦ÈÞ¸¦ ¸Î´Â °Í µîÀÌ ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ºñ´¢±â°ú Áúȯ¿¡ ´ëÇÑ ·¹ÀÌÀú Ä¡·á ÇÁ·ÎÅäÄÝÀ» ÃÖÀûÈ­Çϱâ À§ÇÑ ¿¬±¸°³¹ß¿¡ ÁýÁßÇÏ´Â °ÍÀº ÀÌ ¿ªµ¿ÀûÀÎ ½ÃÀå¿¡¼­ÀÇ ¹Ì·¡ ¼ºÀåÀ» º¸ÀåÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 12¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 13¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 23¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 9.65%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ³ëÀÎ Àα¸ ±ÞÁõ
    • ¹æ±¤¾Ï, Àü¸³¼± ÁúȯÀ» Æ÷ÇÔÇÑ ºñ´¢±â°ú ÁúȯÀÇ Áõ°¡
    • ÀÇ·áºñ ÁöÃâ ÆÐÅÏ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ·¹ÀÌÀú ¼ö¼ú¿¡ µû¸¥ ³ôÀº ¼ö¼ú ºñ¿ë
    • ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦
  • ½ÃÀå ±âȸ
    • ºñ´¢±â¾Ï Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ Á¤ºÎÀÇ ³ë·Â
  • ½ÃÀå °úÁ¦
    • ·¹ÀÌÀú ±â¼úÀÇ ÀÇ·á ÀÀ¿ë¿¡ ´ëÇÑ ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå ·¹ÀÌÀú À¯Çüº°

  • ´ÙÀÌ¿Àµå ·¹ÀÌÀú ½Ã½ºÅÛ
  • Ȧ¹Å ·¹ÀÌÀú ½Ã½ºÅÛ
  • Åø·ý ·¹ÀÌÀú ½Ã½ºÅÛ

Á¦7Àå ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå : ¿ëµµº°

  • Àü¸³¼± ºñ´ëÁõ
  • ºñ±ÙħÀ±¼º ¹æ±¤¾Ï
  • ¿ä·Î°á¼®Áõ

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºñ´¢±â°ú¿ë ÀÇ·á ·¹ÀÌÀú ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Allengers Medical Systems Limited
  • Biolitec
  • Boston Scientific Corporation
  • Convergent Laser Technologies
  • Cook Medical, Inc.
  • Healthtronics, Inc.
  • JenaSurgical GmbH
  • Karl Storz SE & Co. KG
  • Lumenis Ltd.
  • Medency Technology Company
  • Olympus Corporation
  • Quanta System S.p.A.
  • Stryker Corporation
  • Surgical Lasers Inc.
  • Unique Medical Devices
  • Vega Medical
ksm 24.11.29

The Urology Medical Lasers Market was valued at USD 1.25 billion in 2023, expected to reach USD 1.37 billion in 2024, and is projected to grow at a CAGR of 9.65%, to USD 2.39 billion by 2030.

The scope of the urology medical lasers market encompasses devices used in procedures for the treatment of various urological conditions such as benign prostatic hyperplasia, urinary stones, tumors, and strictures. The necessity of these lasers primarily stems from their precision, minimized blood loss, and shorter recovery times compared to traditional surgical methods. They find applications in hospitals, urology clinics, and ambulatory surgical centers, enhancing patient treatment options and aligning with the growing demand for minimally invasive surgeries. The key end-use segments include healthcare providers and facilities focused on urological health management. Key growth drivers influencing this market include the increasing prevalence of urological disorders, advancements in laser technology, aging populations, and expanded healthcare access globally. Technological innovations such as fiber laser technology and partnerships for product development promise new avenues for growth. The market is experiencing an upswing due to rapid adoption in emerging economies and strategic collaborations between manufacturers and health organizations. Meanwhile, challenges such as high equipment costs, a need for skilled operators, regulatory hurdles, and reimbursement issues can impede growth. The competitive landscape shows significant opportunity in untapped regions, with growing research on laser-tissue interaction revealing potential new applications such as sperm mobility improvements and enhanced tissue resection. Innovation can be driven through advancements in compact and portable laser units or those that integrate AI for precise diagnosis and treatment optimization. Sustainability and cost-efficiency in laser design could provide competitive advantages. Despite the promising outlook, limitations are highlighted by competition from alternative treatments and surgical options. Strategic recommendations include focusing on education and training for healthcare providers, investing in marketing in emerging markets, and forming alliances to improve product reach and acceptance. Enhanced focus on R&D to optimize laser treatment protocols for varying urological conditions will be crucial in securing future growth in this dynamic market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.25 billion
Estimated Year [2024] USD 1.37 billion
Forecast Year [2030] USD 2.39 billion
CAGR (%) 9.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urology Medical Lasers Market

The Urology Medical Lasers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid growth in geriatric population
    • Growing urological cases including bladder cancer and prostate diseases
    • Healthcare expenditure patterns
  • Market Restraints
    • High procedural costs associated with laser surgeries
    • Stringent government regulations
  • Market Opportunities
    • Government initiatives taken for diagnosis and treatment of urological cancer
  • Market Challenges
    • Safety concerns related to medical applications of laser technology

Porter's Five Forces: A Strategic Tool for Navigating the Urology Medical Lasers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urology Medical Lasers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urology Medical Lasers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urology Medical Lasers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urology Medical Lasers Market

A detailed market share analysis in the Urology Medical Lasers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urology Medical Lasers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urology Medical Lasers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urology Medical Lasers Market

A strategic analysis of the Urology Medical Lasers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urology Medical Lasers Market, highlighting leading vendors and their innovative profiles. These include Allengers Medical Systems Limited, Biolitec, Boston Scientific Corporation, Convergent Laser Technologies, Cook Medical, Inc., Healthtronics, Inc., JenaSurgical GmbH, Karl Storz SE & Co. KG, Lumenis Ltd., Medency Technology Company, Olympus Corporation, Quanta System S.p.A., Stryker Corporation, Surgical Lasers Inc., Unique Medical Devices, and Vega Medical.

Market Segmentation & Coverage

This research report categorizes the Urology Medical Lasers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Laser Type, market is studied across Diode Laser System, Holmium Laser System, and Thulium Laser System.
  • Based on Application, market is studied across Benign Prostatic Hyperplasia, Non-Muscle-Invasive Bladder Cancer, and Urolithiasis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid growth in geriatric population
      • 5.1.1.2. Growing urological cases including bladder cancer and prostate diseases
      • 5.1.1.3. Healthcare expenditure patterns
    • 5.1.2. Restraints
      • 5.1.2.1. High procedural costs associated with laser surgeries
      • 5.1.2.2. Stringent government regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives taken for diagnosis and treatment of urological cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Safety concerns related to medical applications of laser technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urology Medical Lasers Market, by Laser Type

  • 6.1. Introduction
  • 6.2. Diode Laser System
  • 6.3. Holmium Laser System
  • 6.4. Thulium Laser System

7. Urology Medical Lasers Market, by Application

  • 7.1. Introduction
  • 7.2. Benign Prostatic Hyperplasia
  • 7.3. Non-Muscle-Invasive Bladder Cancer
  • 7.4. Urolithiasis

8. Americas Urology Medical Lasers Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Urology Medical Lasers Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Urology Medical Lasers Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allengers Medical Systems Limited
  • 2. Biolitec
  • 3. Boston Scientific Corporation
  • 4. Convergent Laser Technologies
  • 5. Cook Medical, Inc.
  • 6. Healthtronics, Inc.
  • 7. JenaSurgical GmbH
  • 8. Karl Storz SE & Co. KG
  • 9. Lumenis Ltd.
  • 10. Medency Technology Company
  • 11. Olympus Corporation
  • 12. Quanta System S.p.A.
  • 13. Stryker Corporation
  • 14. Surgical Lasers Inc.
  • 15. Unique Medical Devices
  • 16. Vega Medical
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦